Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 08/06 11:29:59 am
8425.5 GBX   -0.88%
05:18pHealth Care Down As Investors Hedge On Vaccine, Deal Outlook -- Health Care Roundup
DJ
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/31/2020 08/03/2020 08/04/2020 08/05/2020 08/06/2020 Date
8530(c) 8767(c) 8550(c) 8500(c) 8419(c) Last
2 139 111 1 319 813 1 761 364 1 352 567 1 163 787 Volume
-2.53% +2.78% -2.48% -0.58% -0.95% Change
More quotes
Financials (USD)
Sales 2020 26 712 M - -
Net income 2020 3 067 M - -
Net Debt 2020 13 578 M - -
P/E ratio 2020 38,6x
Yield 2020 3,34%
Sales 2021 30 059 M - -
Net income 2021 4 325 M - -
Net Debt 2021 11 695 M - -
P/E ratio 2021 27,8x
Yield 2021 3,38%
Capitalization 110 B 145 B -
EV / Sales 2020 4,64x
EV / Sales 2021 4,06x
Nbr of Employees 70 600
Free-Float 95,7%
More Financials
Company
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows: - oncology (36.8%); - respiratory diseases (22.9%); - cardiovascular, renal and metabolic diseases (18.6%); - other (21.7%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases. Net sales are distributed geographically as follows: the United... 
Sector
Pharmaceuticals
Calendar
08/06Roadshow - Day 4
More about the company
Surperformance© ratings of AstraZeneca PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on ASTRAZENECA PLC
05:18pHealth Care Down As Investors Hedge On Vaccine, Deal Outlook -- Health Care R..
DJ
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
02:54pAstraZeneca Strikes Deal to Produce Covid-19 Vaccine for China
DJ
08:45aFACTBOX : AstraZeneca's potential coronavirus vaccine
RE
07:43aAstraZeneca in first COVID-19 vaccine deal with Chinese company
RE
05:34aAstraZeneca in first COVID-19 vaccine deal with Chinese company
RE
03:50aSHENZHEN KANGTAI BIOLOGICAL PRODUCTS : AstraZeneca in deal with Kangtai Bio to s..
RE
08/05Covid-19 Vaccine Makers Signal Prices
DJ
08/05COVID-19 VACCINE TRIALS HAVE A PROBL : Minority Groups Don't Trust Them
DJ
08/04Brazil, hotbed for COVID-19 vaccine testing, may struggle to produce its own
RE
08/04REDX PHARMA : Shares Skyrocket on AstraZeneca Agreement
DJ
08/03FOCUS : Next big COVID-19 treatment may be manufactured antibodies
RE
08/03UK shares surge as upbeat factory activity data lifts global sentiment; HSBC ..
RE
08/03Gilead Shows the Dangers of Covid-19 Drug Mania -- Heard on the Street
DJ
More news
News in other languages on ASTRAZENECA PLC
05:18pHealth Care Down As Investors Hedge On Vaccine, Deal Outlook -- Health Care R..
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
02:54pAstraZeneca Strikes Deal to Produce Covid-19 Vaccine for China
08:45aFACTBOX : AstraZeneca's potential coronavirus vaccine
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 113,86 $
Last Close Price 84,19 $
Spread / Highest target 72,9%
Spread / Average Target 35,2%
Spread / Lowest Target -28,7%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC11.74%146 635
JOHNSON & JOHNSON0.93%390 711
ROCHE HOLDING AG1.04%299 337
PFIZER, INC.-1.86%213 583
MERCK & CO., INC.-10.24%206 068
NOVARTIS AG-17.36%184 831